Company / PP&E per Share
GeneDx Holdings Corp. PP&E per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$1.63
FY2025
5-year range
$1.27 / $505798.39
FY2021-FY2025
Trend
+28.8%
vs FY2024
Sector context
#86 of 133
Health Care
What the data says
At $1.63, GeneDx Holdings Corp.'s pp&e per share ranks #86 of 133 in the Health Care sector. PP&E per Share returned to growth in FY2025 after 3 years of decline, reaching $1.63.
Based on SEC 10-K filings.
1.63 in FY2025 with a 5-year CAGR of -83.2%.
Declined from $2.76 to $1.63 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -94.5%
- 5-Year CAGR
- -83.2%
- 10-Year CAGR
- -
Sector benchmark
#86 of 133 in Health CareTop 65% of 133This company $1.63 Sector average $11.64
▼
-86.0% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 28.8% year-over-year.
- Ranks #86 out of 133 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2021.
- Lowest pp&e per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.63 | +28.8% |
| FY2024 | $1.27 | -54.1% |
| FY2023 | $2.76 | -100.0% |
| FY2022 | $10042.29 | -98.0% |
| FY2021 | $505798.39 | +4012.3% |
| FY2020 | $12299.75 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026